Regenerative Technologies Corp

Regenerative Technologies Corp (dba Juvent) manufactures the Juvent Micro-Impact Platform, a resonance-based personal wellness device designed for home use. The platform delivers calibrated, low-magnitude micro-impact vibrations tuned to the user's natural body resonance, claimed to support bone health, circulation, balance, mobility, and recovery without joint stress. The company positions the technology as distinct from whole-body vibration systems, emphasizing gentle, controlled micro-impacts rather than high-energy oscillation. Marketed applications include osteoporosis and osteopenia support, joint pain relief, post-menopausal wellness, cardiovascular and lymphatic support, and general mobility maintenance across all ages. The device is FDA-registered and patent-protected. Juvent supports clinical research in micro-impact therapy, citing 90+ published studies on bone health outcomes. The company assembles products in the USA using premium materials and offers direct-to-consumer sales with financing options (0% APR available). Customer service includes in-house repair and rebuild capabilities at their Tennessee facility, with remote support and expedited shipping available. Primary market is wellness-focused consumers aged 40+, including those with bone density concerns, chronic pain, and mobility limitations.